Consequently, IFNɣ immunotherapy is often used to treat human chronic granulomatous disease, cancer, tuberculosis, cystic fibrosis, hepatitis, osteoporosis, scleroderma, and invasive fungal infections [48]. The gene discussed is IFNA1; the disease is chronic granulomatous disease.